- Thai FDA — Food and Drug Administration
Primary regulatory authority for medical cannabis. Issues production, import, and export licenses. Conducts GMP and GACP inspections. Under Ministry of Public Health.
- Production and export licenses
- GMP and GACP inspections
- Import authorizations for research
- Cannabis product registration
- Ministry of Public Health (MOPH) — Policy and oversight
Sets national cannabis policy. Thai cannabis policy has been dynamic — MOPH drove the 2022 decriminalization and the 2024 re-restriction of recreational use.
- National cannabis access policy
- Oversight of Thai FDA
- International treaty compliance (Single Convention)
- Narcotics Control Board (ONCB) — Narcotic control
Office of the Narcotics Control Board. Manages narcotic quotas and international reporting under Single Convention 1961. Issues annual narcotic quotas.
- Annual narcotic quota allocation
- INCB reporting
- Import/export narcotic declarations
- Licensed Producers — Thai FDA licensed
Growing number of Thai FDA licensed cannabis producers. Both domestic (government agencies and private companies) and government-linked entities hold licenses.
- Thai FDA production license
- GMP/GACP compliance
- Annual license renewal
- Hospitals / Clinics / Pharmacies — Medical supply chain
Licensed hospitals, clinics, and pharmacies may dispense medical cannabis to registered patients. Government-linked medical cannabis products distributed via government health facilities.
- Medical facility or pharmacy license
- Registered patient system
- Prescription by licensed physician